bioRxivImmunology
HIV-specific T-cell responses reflect substantive in vivo interactions with infected cells despite long-term therapy
E. Stevenson, A. Ward, R. Truong, A. Thomas, S. H. Huang, T. Dilling, S. Terry, J. Bui, T. Mota, A. Danesh, G. Lee, A. Gramatica, P. Khadka, W. C. Alberto, R. Gandhi, D. McMahon, C. Lalama, R. Bosch, B. Macatangay, J. Cyktor, J. Eron, J. Mellors, R. B. Jones
Abstract
Antiretroviral therapies (ART) durably suppress HIV replication to undetectable levels - however, infection persists in the form of long-lived reservoirs of infected cells with integrated proviruses, that re-seed systemic replication if ART is interrupted. A central tenet of our current understanding of this persistence is that infected cells are shielded from immune recognition and elimination through a lack of antigen expression from proviruses. Efforts to cure HIV infection have therefore focused on reactivating latent proviruses to enable immune-mediated clearance, but these have yet to succeed in driving reductions in viral reservoirs. Here, we revisited the question of whether HIV reservoirs are predominately immunologically silent from a new angle, by querying the dynamics of HIV-specific T-cell responses over long-term ART for evidence of ongoing recognition of HIV-infected cells. We show that T-cell responses to autologous reservoir viruses persist over years, and that the maintenance of HIV-Nef-specific responses was uniquely associated with residual frequencies of infected cells. These responses disproportionately exhibited a cytotoxic, effector functional profile, indicative of recent in vivo recognition of HIV-infected cells. These results indicate substantial visibility of the HIV reservoir to T-cells on stable ART, presenting both opportunities and challenges for the development of therapeutic approaches to curing HIV infection.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- HIV-specific CD8+ T-cell proliferative response 24 weeks after early antiretroviral therapy initiation predicts the subsequent reduction of the viral reservoir
Pien M van Paassen, Alexander O. Pasternak, … Godelieve J. de Bree·bioRxiv·Feb 24, 2025
- A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation
D. B. Reeves, E. R. Duke, … J. T. Schiffer·bioRxiv·Sep 7, 2018
- Selective infection and loss of PRDM1+ LN Tfh cells in uncontrolled HIV infection precludes formation of Tfh reservoirs under ART
Vincent H. Wu, Jayme M.L. Nordin, … Michael R. Betts·bioRxiv·Dec 15, 2025
- Awakening intracellular immunity for functional HIV cure
Alessio Lanna, Federica Rinaldi, Christof Stingone·bioRxiv·Jan 5, 2026
- Proviruses in CD4+ T cells reactive to autologous antigens contribute to nonsuppressible HIV-1 viremia
Fengting Wu, Milica Moskovljevic, … Francesco Roberto Simonetti·Science Translational MedicinePeer-reviewed·Aug 13, 2025
- A New Perspective on HIV Cure
Florian Hladik·F1000ResearchPeer-reviewed·Mar 24, 2015